Literature DB >> 17390189

Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival.

Eddie K Abdalla1, Dario Ribero, Timothy M Pawlik, Daria Zorzi, Steven A Curley, Andrea Muratore, Axel Andres, Gilles Mentha, Lorenzo Capussotti, Jean-Nicolas Vauthey.   

Abstract

PURPOSE: To examine clinical features and outcome of patients who underwent hepatic resection for colorectal liver metastases (LM) involving the caudate lobe. PATIENTS AND METHODS: Consecutive patients who underwent hepatic resection for LM from May 1990 to September 2004 were analyzed from a multicenter database. Demographics, operative data, pathologic margin status, recurrence, and survival were analyzed.
RESULTS: Of 580 patients, 40 (7%) had LM involving the caudate. Six had isolated caudate LM and 34 had LM involving the caudate plus one or more other hepatic segments. Patients with caudate LM were more likely to have synchronous primary colorectal cancer (63% vs. 36%; P = 0.01), multiple LM (70% vs. 51%; P = 0.02) and required extended hepatic resection more often than patients with non-caudate LM (60% vs. 18%; P < 0.001). Only four patients with caudate LM underwent a vascular resection; three at first operation, one after recurrence of a resected caudate tumor. All had primary repair (vena cava, n = 3; portal vein, n = 1). Perioperative complications (43% vs. 28%) and 60-day operative mortality (0% vs. 1%) were similar (caudate vs. non-caudate LM, both P > 0.05). Pathological margins were positive in 15 (38%) patients with caudate LM and in 43 (8%) with non-caudate LM (P < 0.001). At a median follow-up of 40 months, 25 (64%) patients with caudate LM recurred compared with 219 (40%) patients with non-caudate LM (P = 0.01). Patients with caudate LM were more likely to have intrahepatic disease as a component of recurrence (caudate: 51% vs. non-caudate: 25%; P = 0.001). No patient recurred on the vena cava or portal vein. Patients with caudate LM had shorter 5-year disease-free and overall survival than patients with non-caudate LM (disease-free: 24% vs. 44%; P = 0.02; overall: 41% vs. 58%; P = 0.02).
CONCLUSIONS: Patients who undergo hepatic resection for caudate LM often present with multiple hepatic tumors and tumors in proximity to the major hepatic veins. Extended hepatectomy is required in the majority, although vascular resection is not frequently necessary; when performed, primary repair is usually possible. Despite resection in this population of patients with multiple and bilateral tumors, and despite close-margin and positive-margin resection in a significant proportion, recurrence on the portal vein or vena cava was not observed, and long-term survival is accomplished (41% 5-year overall survival).

Entities:  

Mesh:

Year:  2007        PMID: 17390189     DOI: 10.1007/s11605-006-0045-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  30 in total

1.  Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations.

Authors:  J N Vauthey; A Chaoui; K A Do; M M Bilimoria; M J Fenstermacher; C Charnsangavej; M Hicks; G Alsfasser; G Lauwers; I F Hawkins; J Caridi
Journal:  Surgery       Date:  2000-05       Impact factor: 3.982

2.  Surgical outcomes of isolated caudate lobe resection: a single series of 19 patients.

Authors:  Juan M Sarmiento; Florencia G Que; David M Nagorney
Journal:  Surgery       Date:  2002-10       Impact factor: 3.982

3.  Hepatic resection for primary or secondary malignancies with involvement of the inferior vena cava: is this operation safe or hazardous?

Authors:  Bruno Nardo; Giorgio Ercolani; Roberto Montalti; Riccardo Bertelli; Andrea Gardini; Paolo Beltempo; Lorenza Puviani; Vincenzo Pacilè; Marco Vivarelli; Antonino Cavallari
Journal:  J Am Coll Surg       Date:  2005-11       Impact factor: 6.113

4.  Trends in long-term survival following liver resection for hepatic colorectal metastases.

Authors:  Michael A Choti; James V Sitzmann; Marcelo F Tiburi; Wuthi Sumetchotimetha; Ram Rangsin; Richard D Schulick; Keith D Lillemoe; Charles J Yeo; John L Cameron
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

5.  Complete resection of the caudate lobe of the liver with tumor: technique and experience.

Authors:  J Fan; Z Q Wu; Z Y Tang; J Zhou; S J Qiu; Z C Ma; X D Zhou; Y Q Yu
Journal:  Hepatogastroenterology       Date:  2001 May-Jun

6.  Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Authors:  Timothy M Pawlik; Charles R Scoggins; Daria Zorzi; Eddie K Abdalla; Axel Andres; Cathy Eng; Steven A Curley; Evelyne M Loyer; Andrea Muratore; Gilles Mentha; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

Review 7.  The caudate lobe of the liver: implications of embryology and anatomy for surgery.

Authors:  Eddie K Abdalla; Jean-Nicolas Vauthey; Claude Couinaud
Journal:  Surg Oncol Clin N Am       Date:  2002-10       Impact factor: 3.495

8.  Anterior transhepatic approach for isolated resection of the caudate lobe of the liver.

Authors:  J Yamamoto; T Kosuge; K Shimada; S Yamasaki; T Takayama; M Makuuchi
Journal:  World J Surg       Date:  1999-01       Impact factor: 3.352

9.  [Surgical approaches to segment I for malignant tumors (20 cases)].

Authors:  D Elias; P H Lasser; E Desruennes; H Mankarios; B Detroz
Journal:  J Chir (Paris)       Date:  1993 Aug-Sep

10.  An isolated, complete resection of the caudate lobe, including the paracaval portion, for hepatocellular carcinoma.

Authors:  T Kosuge; J Yamamoto; T Takayama; K Shimada; S Yamasaki; M Makuuchi; H Hasegawa
Journal:  Arch Surg       Date:  1994-03
View more
  4 in total

Review 1.  Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Guy Maddern; Moritz Koch; Thomas J Hugh; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Jean-Nicolas Vauthey; Myrddin Rees; Rene Adam; Ronald P Dematteo; Paul Greig; Val Usatoff; Simon Banting; Masato Nagino; Lorenzo Capussotti; Yukihiro Yokoyama; Mark Brooke-Smith; Michael Crawford; Christopher Christophi; Masatoshi Makuuchi; Markus W Büchler; Jürgen Weitz
Journal:  HPB (Oxford)       Date:  2011-06-07       Impact factor: 3.647

2.  Parenchyma-preserving hepatic resection for colorectal liver metastases.

Authors:  Maximilian von Heesen; Jochen Schuld; Jens Sperling; Frank Grünhage; Frank Lammert; Sven Richter; Martin K Schilling; Otto Kollmar
Journal:  Langenbecks Arch Surg       Date:  2011-11-17       Impact factor: 3.445

3.  Two-Stage Hepatectomy and ALPPS for Advanced Bilateral Liver Metastases: a Tailored Approach Balancing Risk and Outcome.

Authors:  Janine Baumgart; Florian Jungmann; Fabian Bartsch; Michael Kloth; Jens Mittler; Stefan Heinrich; Hauke Lang
Journal:  J Gastrointest Surg       Date:  2019-02-28       Impact factor: 3.452

4.  Transarterial chemoembolization is ineffective for neuroendocrine tumors metastatic to the caudate lobe: a single institution review.

Authors:  Lawrence A Shirley; Megan McNally; Ravi Chokshi; Natalie Jones; Patrick Tassone; Gregory Guy; Hooman Khabiri; Carl Schmidt; Manisha Shah; Mark Bloomston
Journal:  World J Surg Oncol       Date:  2015-05-01       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.